MY8400058A - Benz[g]-isoquinoline deprivatives and their preparation - Google Patents

Benz[g]-isoquinoline deprivatives and their preparation

Info

Publication number
MY8400058A
MY8400058A MY58/84A MY8400058A MY8400058A MY 8400058 A MY8400058 A MY 8400058A MY 58/84 A MY58/84 A MY 58/84A MY 8400058 A MY8400058 A MY 8400058A MY 8400058 A MY8400058 A MY 8400058A
Authority
MY
Malaysia
Prior art keywords
deprivatives
benz
isoquinoline
preparation
isoquinoline deprivatives
Prior art date
Application number
MY58/84A
Other languages
English (en)
Inventor
Jean-Michel Bastian
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH863176A external-priority patent/CH622782A5/de
Priority claimed from CH863276A external-priority patent/CH622783A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8400058A publication Critical patent/MY8400058A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY58/84A 1976-07-06 1984-12-30 Benz[g]-isoquinoline deprivatives and their preparation MY8400058A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH863176A CH622782A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives
CH863276A CH622783A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives

Publications (1)

Publication Number Publication Date
MY8400058A true MY8400058A (en) 1984-12-31

Family

ID=25703556

Family Applications (1)

Application Number Title Priority Date Filing Date
MY58/84A MY8400058A (en) 1976-07-06 1984-12-30 Benz[g]-isoquinoline deprivatives and their preparation

Country Status (19)

Country Link
US (1) US4150136A (fr)
JP (1) JPS537681A (fr)
AT (1) AT366369B (fr)
CA (1) CA1094561A (fr)
DE (1) DE2728831A1 (fr)
DK (1) DK285077A (fr)
ES (2) ES460371A1 (fr)
FI (1) FI65242C (fr)
FR (1) FR2357547A1 (fr)
GB (1) GB1582783A (fr)
IE (1) IE45241B1 (fr)
IL (1) IL52449A (fr)
MY (1) MY8400058A (fr)
NL (1) NL7707307A (fr)
NZ (1) NZ184547A (fr)
PH (1) PH14074A (fr)
PT (1) PT66758B (fr)
SE (2) SE7707445L (fr)
SU (1) SU692559A3 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325803A (en) * 1964-10-01 1967-06-13 Ibm Deflection control circuit

Also Published As

Publication number Publication date
CA1094561A (fr) 1981-01-27
AT366369B (de) 1982-04-13
ES476889A1 (es) 1979-07-16
GB1582783A (en) 1981-01-14
FR2357547B1 (fr) 1980-02-15
ATA477577A (de) 1981-08-15
FI771986A (fr) 1978-01-07
NL7707307A (nl) 1978-01-10
IL52449A (en) 1981-09-13
PH14074A (en) 1981-01-26
AU2677177A (en) 1979-01-11
NZ184547A (en) 1980-08-26
US4150136A (en) 1979-04-17
PT66758B (fr) 1979-03-12
JPS537681A (en) 1978-01-24
IE45241B1 (en) 1982-07-14
SE8207394D0 (sv) 1982-12-23
DK285077A (da) 1978-01-07
DE2728831A1 (de) 1978-01-19
FI65242C (fi) 1984-04-10
IE45241L (en) 1978-01-06
IL52449A0 (en) 1977-10-31
SE7707445L (sv) 1978-01-07
SU692559A3 (ru) 1979-10-15
FR2357547A1 (fr) 1978-02-03
FI65242B (fi) 1983-12-30
ES460371A1 (es) 1979-05-01
SE8207394L (sv) 1982-12-23
PT66758A (fr) 1977-08-01

Similar Documents

Publication Publication Date Title
JPS52105162A (en) Phthleic derivatives and preparation thereof
JPS5422394A (en) Substituted naphthyridinone and its preparation
IL59567A0 (en) Oxiranylmethyltetrahydropyran derivative and its preparation
IL60155A0 (en) Substituted phenoxybenzylalcohols and their preparation
IL52353A0 (en) 4-hydroxyphenylalkynolamine derivatives and their preparation
SG42883G (en) Isoquinoline and naphthyridine substituted aminoalkoxyphenyl derivatives
IL49516A (en) 3-amino-4-deoxo-4-imino and amino-rifamycins and their preparation
JPS5262399A (en) Polyamideterpolymer and preparation thereof
JPS51138609A (en) 12222tetrafluoroethyll fluoromethilether and its preparation
JPS5312861A (en) Benzimdazole derivative and its preparation
IL50080A0 (en) New azabicycloheptanes and their preparation
GB2001630B (en) Inosadiamine derivatives and their preparation
JPS51138667A (en) Anthraquinoneebissamizine and preparation*
JPS51143630A (en) Nnbenzyll2* 22dimethoxyyacetamide and preparation
IL54252A0 (en) Novel -aryl-acetamide derivatives and their preparation
IL51092A0 (en) Naphthyridine derivatives and their preparation
JPS5212158A (en) Epoxyandrostane and preparation thereof
IL52668A (en) 7 -amino-1-oxa-1-dethiacephalosporins and their preparation
JPS5251364A (en) Thiazolizine derivatives and preparation thereof
IL54013A0 (en) Everninomicin derivatives and their preparation
MY8400058A (en) Benz[g]-isoquinoline deprivatives and their preparation
GB2000776B (en) Tunicamine derivatives and their preparation
JPS52116462A (en) 22oxoopyrrolidine derivative and preparation thereof
JPS5312863A (en) Benzodithiolan derivative and its preparation
JPS5226793A (en) Visual field meter